Reference results for Alemtuzumab from

Alemtuzumab - Wikipedia, the free encyclopedia

Alemtuzumab is a drug used in the treatment of chronic lymphocytic leukemia (CLL), cutaneous T-cell lymphoma (CTCL) and T-cell lymphoma under the trade names Campath, ...

Alemtuzumab: Indications, Side Effects, Warnings -

Easy to read patient leaflet for alemtuzumab. Includes indications, proper use, special instructions, precautions, and possible side effects. Consumer Home

Campath, alemtuzumab is a major step forward in the treatment of B-cell chronic lymphocytic leukemia (B-CLL).

Alemtuzumab - National Cancer Institute

This page contains brief information about alemtuzumab and a collection of links to more information about the use of this drug, research results, and ongoing ...

Campath (Alemtuzumab) Drug Information: Description, User ...

Learn about the prescription medication Campath (Alemtuzumab), drug uses, dosage, side effects, drug interactions, warnings, reviews and patient labeling.

FDA Approval for Alemtuzumab (Lemtrada) in MS - Medscape

The US Food and Drug Administration (FDA) has approved alemtuzumab (Lemtrada, Genzyme, a Sanofi Company) for the treatment of relapsing forms of multiple sclerosis (MS).

Alemtuzumab | definition of alemtuzumab by Medical dictionary

Alemtuzumab Definition Alemtuzumab is sold as Campath in the United States. Alemtuzumab is a humanized monoclonal antibody that selectively binds to CD52, a protein ...

ALEMTUZUMAB - INJECTION (Campath) side effects, medical ...

Consumer information about the medication ALEMTUZUMAB - INJECTION (Campath), includes side effects, drug interactions, recommended dosages, and storage information.

Alemtuzumab | Multiple Sclerosis Society UK

Alemtuzumab (sold under the brand name Lemtrada, and in the past also known as CAMPATH-1H) is a treatment for relapsing MS. Who can take alemtuzumab?

Alemtuzumab (Professional Patient Advice) -

Professional guide for Alemtuzumab. Includes: pharmacology, pharmacokinetics, contraindications, interactions, adverse reactions and more.